Collection of blood samples to study inflammation in psychiatric disorders

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect biological samples and associated phenotypic data from patients diagnosed with various psychiatric disorders, including schizoaffective disorder and bipolar disorder. The hypothesis is that peripheral inflammatory biomarkers may be common across these conditions, potentially leading to better diagnostic and prognostic tools. Participants will undergo standard blood sampling procedures and interviews with psychiatrists to assess their symptoms using standardized scales. The study builds on previous research and aims to contribute to a larger European research initiative.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Major patient
* Patient with one of the following diagnoses confirmed by a psychiatrist:

  * Characterized depressive episode with psychotic features,
  * Bipolar disorder type I
  * Bipolar disorder type II
  * Schizoaffective disorder
  * Schizophrenia
  * Schizophreniform disorder
* Patient under psychiatric care at Nantes University Hospital
* Patients weighing at least 45kg
* Patient affiliated to a social security scheme or beneficiary of such a scheme
* Patient who has given informed consent to participate in the study

Exclusion Criteria:

* Pregnant,
* History of cancer in the last 5 years,
* Vaccination within the last 4 weeks,
* Acute or chronic infection,
* Medical history of organ transplant,
* Medical history of autoimmune disease,
* Hearing impairment making it impossible to complete study questionnaires,
* Patient under court protection

Where it's running

• Nantes University Hospital
  Nantes, France Recruiting

Study contacts

• Principal investigator: Anne Sauvaget — Nantes University Hospital
• Study coordinator: Anne Sauvaget
• Email: anne.sauvaget@chu-nantes.fr
• Phone: +33 240084795

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Testing BXCL501 for agitation in children with schizophrenia and bipolar disorder

  This study is testing if a new medication called BXCL501 can help reduce agitation in children and teens aged 10-17 with bipolar disorder or schizophrenia.

  Recruiting at 4 sites Phase 1 BioXcel Therapeutics Inc · Anaheim, California and 4 other locations · NCT05025605

• Type D Personality and Life Satisfaction in Bipolar II and Major Depressive Disorder

  This study tests how Type D personality relates to life satisfaction in adults with Bipolar II or Major Depressive Disorder and in healthy controls.

  Recruiting Elazığ Mental Health and Diseases Hospital · Elâzığ · NCT07679204

• Using magnetic stimulation to improve cognition in psychotic disorders

  This study is testing whether a type of brain stimulation called TMS can help improve thinking skills in people with psychotic disorders like schizophrenia and bipolar disorder.

  Recruiting at 2 sites Mclean Hospital · Belmont, Massachusetts and 1 other locations · NCT06107764

• Investigating how melatonin levels relate to lithium response in bipolar disorder

  This study is trying to see if melatonin levels can help predict how well lithium treatment works for people with Bipolar Disorder I.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris, Île-de-France Region · NCT05878730

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.